Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

the chemours company - CC

CC

Close Chg Chg %
12.95 -0.42 -3.24%

Closed Market

12.53

-0.42 (3.24%)

Volume: 2.21M

Last Updated:

Dec 4, 2025, 4:00 PM EDT

Trade Now

Company Overview: the chemours company - CC

CC Key Data

Open

$12.98

 Day Range

12.46 - 13.05

52 Week Range

9.13 - 22.27

 Market Cap

$1.94B

Shares Outstanding

149.89M

 Public Float

148.77M

Beta

1.59

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$2.22

Yield

401.33%

 Dividend

$0.09

EX-DIVIDEND DATE

Nov 14, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

3.09M

  

CC Performance

1 Week
 
 -1.95%
 
1 Month
 
 0.24%
 
3 Months
 
 -19.92%
 
1 Year
 
 -40.29%
 
5 Years
 
 -51.82%
 

CC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About the chemours company - CC

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductors and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014 and is headquartered in Wilmington, DE.

CC At a Glance

The Chemours Co.
1007 Market Street
Wilmington, Delaware 19801
Phone 1-302-773-1000 Revenue 5.78B
Industry Chemicals: Specialty Net Income 86.00M
Sector Process Industries Employees 6,000
Fiscal Year-end 12 / 2025
View SEC Filings

CC Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 29.509
Price to Sales Ratio 0.439
Price to Book Ratio 4.181
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 8.143
Enterprise Value to Sales 1.069
Total Debt to Enterprise Value 0.705

CC Efficiency

Revenue/Employee 963,666.667
Income Per Employee 14,333.333
Receivables Turnover 7.509
Total Asset Turnover 0.733

CC Liquidity

Current Ratio 1.678
Quick Ratio 0.862
Cash Ratio 0.395

CC Profitability

Gross Margin 19.924
Operating Margin 7.921
Pretax Margin 2.196
Net Margin 1.487
Return on Assets 1.091
Return on Equity 12.826
Return on Total Capital 1.734
Return on Invested Capital 1.758

CC Capital Structure

Total Debt to Total Equity 721.026
Total Debt to Total Capital 87.82
Total Debt to Total Assets 57.951
Long-Term Debt to Equity 703.311
Long-Term Debt to Total Capital 85.662
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for The Chemours Company - CC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
6.34B 6.79B 6.03B 5.78B
Sales Growth
+27.69% +7.08% -11.29% -4.07%
Cost of Goods Sold (COGS) incl D&A
4.96B 5.16B 4.72B 4.63B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
317.00M 291.00M 307.00M 301.00M
Depreciation
309.00M 286.00M 297.00M 301.00M
Amortization of Intangibles
- 8.00M 5.00M 10.00M
COGS Growth
+27.07% +3.97% -8.59% -1.82%
Gross Income
1.38B 1.64B 1.31B 1.15B
Gross Income Growth
+29.98% +18.22% -19.82% -12.13%
Gross Profit Margin
+21.80% +24.07% +21.75% +19.92%
2021 2022 2023 2024 5-year trend
SG&A Expense
674.00M 828.00M 634.00M 694.00M
Research & Development
107.00M 118.00M 108.00M 109.00M
Other SG&A
567.00M 710.00M 526.00M 585.00M
SGA Growth
+8.71% +22.85% -23.43% +9.46%
Other Operating Expense
- - - -
-
Unusual Expense
67.00M 7.00M 925.00M 112.00M
EBIT after Unusual Expense
642.00M 800.00M (248.00M) 346.00M
Non Operating Income/Expense
219.00M 104.00M 138.00M 45.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
43.00M 55.00M 45.00M 43.00M
Interest Expense
185.00M 163.00M 208.00M 264.00M
Interest Expense Growth
-11.48% -11.89% +27.61% +26.92%
Gross Interest Expense
190.00M 170.00M 215.00M 274.00M
Interest Capitalized
5.00M 7.00M 7.00M 10.00M
Pretax Income
676.00M 741.00M (318.00M) 127.00M
Pretax Income Growth
+277.65% +9.62% -142.91% +139.94%
Pretax Margin
+10.65% +10.91% -5.28% +2.20%
Income Tax
68.00M 163.00M (81.00M) 41.00M
Income Tax - Current - Domestic
72.00M 96.00M 20.00M 6.00M
Income Tax - Current - Foreign
72.00M 47.00M 57.00M 62.00M
Income Tax - Deferred - Domestic
(75.00M) 6.00M (136.00M) (21.00M)
Income Tax - Deferred - Foreign
(1.00M) 14.00M (22.00M) (6.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
43.00M 55.00M 45.00M 43.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
608.00M 578.00M (237.00M) 86.00M
Minority Interest Expense
- - - 1.00M
-
Net Income
608.00M 578.00M (238.00M) 86.00M
Net Income Growth
+177.63% -4.93% -141.18% +136.13%
Net Margin Growth
+9.58% +8.51% -3.95% +1.49%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
608.00M 578.00M (238.00M) 86.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
608.00M 578.00M (238.00M) 86.00M
EPS (Basic)
3.6861 3.7204 -1.5983 0.5753
EPS (Basic) Growth
+177.19% +0.93% -142.96% +135.99%
Basic Shares Outstanding
164.94M 155.36M 148.91M 149.49M
EPS (Diluted)
3.6041 3.6512 -1.5983 0.5727
EPS (Diluted) Growth
+173.76% +1.31% -143.77% +135.83%
Diluted Shares Outstanding
168.70M 158.30M 148.91M 150.17M
EBITDA
1.03B 1.10B 984.00M 759.00M
EBITDA Growth
+34.29% +7.02% -10.38% -22.87%
EBITDA Margin
+16.17% +16.16% +16.33% +13.13%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 16.444
Number of Ratings 11 Current Quarters Estimate 0.082
FY Report Date 12 / 2025 Current Year's Estimate 0.98
Last Quarter’s Earnings 0.20 Median PE on CY Estimate N/A
Year Ago Earnings 1.21 Next Fiscal Year Estimate 1.818
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 6 10 10
Mean Estimate 0.08 0.20 0.98 1.82
High Estimates 0.49 0.32 1.40 2.15
Low Estimate -0.04 0.12 0.79 1.46
Coefficient of Variance 199.15 37.60 16.68 11.88

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 6
OVERWEIGHT 0 0 0
HOLD 4 3 4
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for The Chemours Company - CC

Date Name Shares Transaction Value
Aug 13, 2025 Denise M. Dignam President & CEO; Director 191,546 Open market or private purchase of non-derivative security Non-derivative transaction at $12.06 per share 2,310,044.76
Mar 6, 2025 Damian Gumpel See Remarks 79,436 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Diane Picho See Remarks 31,175 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Kristine M. Wellman SVP, GC & Corp. Secretary 52,458 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Kristine M. Wellman SVP, GC & Corp. Secretary 49,505 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 David A. Will Chief Accounting Officer 18,704 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 David A. Will Chief Accounting Officer 17,985 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 David A. Will Chief Accounting Officer 26,395 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Denise M. Dignam President & CEO; Director 367,866 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Denise M. Dignam President & CEO; Director 353,717 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Damian Gumpel See Remarks 82,613 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Shane W. Hostetter Chief Financial Officer 54,035 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Damian Gumpel See Remarks 110,479 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Damian Gumpel See Remarks 23,899 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Alvenia Scarborough SVP Corp Communications & CBO 20,886 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Alvenia Scarborough SVP Corp Communications & CBO 20,083 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Alvenia Scarborough SVP Corp Communications & CBO 21,812 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Leslie M. Turner Director 2,886 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Joseph D. Kava Director 2,886 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Shane W. Hostetter Chief Financial Officer 94,460 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

The Chemours Company in the News